WILLIAM BATES, DO

Transitional care management services for problem of at least moderate complexity

Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use

New patient office or other outpatient visit, 45-59 minutes

Established patient office or other outpatient visit, 30-39 minutes

Removal of impacted ear wax

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Established patient office or other outpatient visit, 20-29 minutes

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage

Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)

Testing for presence of drug, read by direct observation

Administration of vaccine

Annual depression screening, 5 to 15 minutes

Injection of drug or substance under skin or into muscle

Detection test by immunoassay with direct visual observation for streptococcus, group a (strep)

Detection test by immunoassay with direct visual observation for influenza virus

Administration of influenza virus vaccine

Complete blood cell count (red cells, white blood cell, platelets), automated test

Administration of pneumococcal vaccine

Injection, methylprednisolone acetate, 40 mg

Insertion of needle into vein for collection of blood sample

Automated urinalysis test

Injection, dexamethasone sodium phosphate, 1 mg